Abstract
A novel capillary zone electrophoresis (CZE) method is, for the first time, developed for effective separation and simultaneous determination of ceftriaxone sodium and levofloxacin in human urine. The electrophoresis conditions were investigated and optimized. A 25 mM disodium tetraborate buffer adjusted with sodium hydroxide or phosphoric acid to pH 9.2 was used and the peak area was determined with UV detection under 20 kV separation voltages. Under optimized conditions, the two drugs can be separated effectively. Good linearity of quantitative analysis was achieved in the range of 10 – 500 μg mL – 1 for ceftriaxone sodium and 25 – 500 μg mL – 1 for levofloxacin with the correlation coefficients (r) of > 0.999. The limits of detection (LOD) for ceftriaxone sodium and levofloxacin were 2.5 and 7.5 μg mL – 1, respectively. Their average recovery from human urine was 99.15 % with the RSD of 0.65 – 1.54 % for ceftriaxone sodium, and 99.57 % with the RSD of 0.2 – 2.0% for levofloxacin. The proposed method is simple, rapid and accurate, and provides the sensitivity and linearity necessary for selective and simultaneous analysis of the test drugs in human urine at clinically relevant concentrations.
Keywords: Capillary zone electrophoresis, Ceftriaxone sodium, Levofloxacin, Urine
Current Analytical Chemistry
Title:Effective Separation and Simultaneous Detection of Ceftriaxone Sodium and Levofloxacin in Human Urine by Capillary Zone Electrophoresis
Volume: 9 Issue: 1
Author(s): Hanwen Sun, Yanli Zuo
Affiliation:
Keywords: Capillary zone electrophoresis, Ceftriaxone sodium, Levofloxacin, Urine
Abstract: A novel capillary zone electrophoresis (CZE) method is, for the first time, developed for effective separation and simultaneous determination of ceftriaxone sodium and levofloxacin in human urine. The electrophoresis conditions were investigated and optimized. A 25 mM disodium tetraborate buffer adjusted with sodium hydroxide or phosphoric acid to pH 9.2 was used and the peak area was determined with UV detection under 20 kV separation voltages. Under optimized conditions, the two drugs can be separated effectively. Good linearity of quantitative analysis was achieved in the range of 10 – 500 μg mL – 1 for ceftriaxone sodium and 25 – 500 μg mL – 1 for levofloxacin with the correlation coefficients (r) of > 0.999. The limits of detection (LOD) for ceftriaxone sodium and levofloxacin were 2.5 and 7.5 μg mL – 1, respectively. Their average recovery from human urine was 99.15 % with the RSD of 0.65 – 1.54 % for ceftriaxone sodium, and 99.57 % with the RSD of 0.2 – 2.0% for levofloxacin. The proposed method is simple, rapid and accurate, and provides the sensitivity and linearity necessary for selective and simultaneous analysis of the test drugs in human urine at clinically relevant concentrations.
Export Options
About this article
Cite this article as:
Hanwen Sun, Yanli Zuo , Effective Separation and Simultaneous Detection of Ceftriaxone Sodium and Levofloxacin in Human Urine by Capillary Zone Electrophoresis, Current Analytical Chemistry 2013; 9 (1) . https://dx.doi.org/10.2174/1573411011309010157
DOI https://dx.doi.org/10.2174/1573411011309010157 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Multiple Roles of the Extracellular Matrix in Inflammation
Current Pharmaceutical Design Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer’s Disease
Recent Patents on Anti-Infective Drug Discovery Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review
Recent Patents on Drug Delivery & Formulation Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment
Current Pharmaceutical Design Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
Current Pharmaceutical Design Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design The Protective Function of Human C-reactive Protein in Mouse Models of Streptococcus pneumoniae Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Anatomical and Functional Relationships Between Sensory Nerves and Mast Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacogenomics and Severe Infections: The Role of the Genomes of Both the Host and the Pathogen
Current Pharmacogenomics Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Host-Cell Survival and Death During Chlamydia Infection
Current Immunology Reviews (Discontinued) Inflammation and Immunology of the Vitreoretinal Compartment
Inflammation & Allergy - Drug Targets (Discontinued) Antifungal Azole Derivatives and their Pharmacological Potential: Prospects & Retrospects
The Natural Products Journal Immunotoxins and Neuropeptide-Toxin Conjugates Experimental Applications
Mini-Reviews in Medicinal Chemistry The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
Current Medicinal Chemistry Penicillium marneffei and its Pulmonary Involvements
Current Respiratory Medicine Reviews Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Research Advances in Neuroblastoma Immunotherapy
Current Pediatric Reviews